# Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men

> **NCT00467870** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 531 (actual)

## Conditions studied

- Hypogonadism
- Primary Hypogonadism
- Secondary Hypogonadism

## Interventions

- **DRUG:** Testosterone Undecanoate 750 mg
- **DRUG:** Testosterone Undecanoate 1000 mg

## Key facts

- **NCT ID:** NCT00467870
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 531 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467870, "Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00467870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*